MGC Pharmaceutical receives Health Canada approval

Published at May 30, 2016, in ASX Biotechs

Following on from last week’s news that MGC Pharmaceutical (ASX:MXC) had received FDA approval to sell and distribute its CBD-based cosmetic products across the US, comes the news that Health Canada has also given MGC Pharmaceuticals regulatory approval.

Health Canada approval enables MGC Pharmaceuticals to pursue distribution and sales agreements in a market estimated to be $US1.9 billion.

MGC Pharmaceuticals is currently in negotiations on distribution agreements in Canada to facilitate sales into this key market.

The Canadian market is a leader in the global medicinal field, and with pharmaceutical ambitions as well as a retail agenda, approval in this region is critical to MGC Pharmaceutical’s long-term business plan.

“MGC Pharmaceuticals has moved forward with its commercialisation strategy for its CBD cosmetics range at a rapid pace, delivering key regulatory approvals, distribution agreements and commencing sales in recent months,” said MGC Pharmaceuticals co-founder and managing director Nativ Segev.

“Our approval from Health Canada is another strong step forward, enabling us to expand our geographic sales reach for the products into Canada, which has a very progressive attitude and legislation for medicinal cannabis and related product markets.

MGC Pharmaceuticals has now managed to gain approval from the FDA in the US, the European Commission’s Cosmetic products Notification Portal (CPNP) for its cosmetics product line.

The company is also awaiting approval in Australia from the Australian Therapeutic Good Administration (TGA).

It is expected the TGA will hand down its decision shortly. If favourable, MGC Pharmaceuticals would be able to sell the cosmetics product line to Australian consumers and MXC’s shareholders.

View Our Investment Portfolios

S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.

Conflict of Interest Notice

S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.

Publishers Notice

The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.

Australian ASX Small Cap stocks | Why is Australia’s leading small cap publication

Founded seven years ago, is Australia’s leading and longest standing website for investor and finance news, education and expert opinion.

Published by StocksDigital, Finfeed was created to report daily on the comings and goings of ASX listed stocks in the small cap market.

As the first digital publication dedicated specifically to this space, Finfeed soon became the most trusted publication in the market, quickly garnering over two million page views – a number that continues to rise. provides its readers with informative articles that tackle the latest in market moving #ASX small cap news, plus exclusive content you won’t find anywhere else. It is aimed at those with an interest in investing, market education, company performance, start-ups and much more. is the only media organisation operating under the strength of a Financial Services License and is backed by leading journalists and analysts all with brands of their own.

The website aims to inform, educate and entertain with content that drills down into the heart of financial matters.

Finfeed is a leading source of investor and market information, with everything investors need to know about how to invest written in a way that anyone can understand. 

Over the years, the website has expanded beyond exclusively reporting on small caps, to profile Australia’s leading ASX listed small, mid and large caps as well as some of the country’s most successful CEOs and business leaders to find out what makes them tick.

Every day you will find fresh content covering:

Fast Facts

Over 4,000 articles published

Over 2.3 Million Page Views and counting

Over 10,000 followers on social media

Subscriber list growing by 2% monthly

Thanks for subscribing!